| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
V39465-1mg |
≥99% | ￥2760.00 |
货期：3-5天 | - | - | - | - |
|
V39465-5mg |
≥99% | ￥6390.00 |
货期：3-5天 | - | - | - | - |
|
V39465-10mg |
≥99% | ￥8730.00 |
货期：3-5天 | - | - | - | - |
|
V39465-25mg |
≥99% | ￥12900.00 |
货期：3-5天 | - | - | - | - |
|
V39465-50mg |
≥99% | ￥17500.00 |
货期：3-5天 | - | - | - | - |
|
V39465-100mg |
≥99% | ￥23600.00 |
货期：3-5天 | - | - | - | - |
|
| 体内研究： | Dogs receiving 0.3 mg dirlotapide/kg once daily have a small but significant (P=0.018) decrease (6.16 ± 2.22%, mean ± SD) in crude fat digestibility compared with the placebo-treated food-restricted dogs, but no difference in crude protein, dry matter, or energy digestibility is observed. Dirlotapide effectively reduces appetite and energy intake without affecting nutrient digestibility, except for a minimal decrease in fat digestibility. Dirlotapide (0.5 mg/kg) results in a high rate of weight loss (3.3% weekly) and anorexia, emesis, and loose stools for some dogs. Dirlotapide produces weight loss by both reducing appetite (about 90% of the weight loss activity) and by increasing fecal fat excretion (about 10% of the weight loss activity). | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 溶解性： | DMSO | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京